Evidence map›Paper›PMID 38959306›Full record

ArticleScience advances2024

Optimizing the timing of an end-of-outbreak declaration: Ebola virus disease in the Democratic Republic of the Congo.

William S Hart, Jack M Buckingham, Mory Keita, Steve Ahuka-Mundeke, Philip K Maini, Jonathan A Polonsky, Robin N Thompson

Abstract read
In one paragraph

Article in Science advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

William S HartWolfson Centre for Mathematical Biology, Mathematical Institute, University of Oxford, Oxford OX2 6GG, UK.ORCID 0000-0002-2504-6860
Jack M BuckinghamEPSRC Centre for Doctoral Training in Mathematics for Real-World Systems, Mathematics Institute, University of Warwick, Coventry CV4 7AL, UK.ORCID 0000-0002-0565-923X
Mory KeitaWorld Health Organization, Regional Office for Africa, Brazzaville, Republic of the Congo.
Steve Ahuka-MundekeInstitut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.
Philip K MainiWolfson Centre for Mathematical Biology, Mathematical Institute, University of Oxford, Oxford OX2 6GG, UK.
Jonathan A PolonskyGeneva Centre of Humanitarian Studies, University of Geneva, Geneva 1205, Switzerland.
Robin N ThompsonWolfson Centre for Mathematical Biology, Mathematical Institute, University of Oxford, Oxford OX2 6GG, UK.

Funding

World Health Organization 001
6 · The paper itself

Abstract

Following the apparent final case in an Ebola virus disease (EVD) outbreak, the decision to declare the outbreak over must balance societal benefits of relaxing interventions against the risk of resurgence. Estimates of the end-of-outbreak probability (the probability that no future cases will occur) provide quantitative evidence that can inform the timing of an end-of-outbreak declaration. An existing modeling approach for estimating the end-of-outbreak probability requires comprehensive contact tracing data describing who infected whom to be available, but such data are often unavailable or incomplete during outbreaks. Here, we develop a Markov chain Monte Carlo-based approach that extends the previous method and does not require contact tracing data. Considering data from two EVD outbreaks in the Democratic Republic of the Congo, we find that data describing who infected whom are not required to resolve uncertainty about when to declare an outbreak over.

Indexed as

Disease OutbreaksHemorrhagic Fever, EbolaDemocratic Republic of the CongoEbolavirusHumansMarkov ChainsMonte Carlo Method

Identifiers

PMID38959306
PMCPMC11221504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.